ANN ARBOR, Mich., April 16 /PRNewswire/ -- Accuri Cytometers Inc., a life sciences company developing revolutionary bench-top flow cytometer systems, today announced the completion of a $5 million Series B financing led by Baird Venture Partners (BVP), the U.S.-based venture capital fund of Baird Private Equity. Arboretum Ventures of Ann Arbor co-led the financing. Both firms are new investors in Accuri, which intends to use the Series B proceeds for the ongoing testing and upcoming commercial launch of the Accuri C6 Flow Cytometer(TM) System. Pete Shagory of BVP and Tim Petersen of Arboretum will join the company's Board of Directors.
